Millar, a leading manufacturer of MEMS and sensors in the medical sector, has announced a compelling strategic move to acquire Sentron in the Netherlands. Sentron is a company known for the manufacture of fully integrated pressure and pH sensors and is currently controlled by Wellinq, a European company. The proposed acquisition is considered a major milestone in the development of both companies and opens up great opportunities for future innovation and global expansion. The entire transaction aims to advance medical understanding and scientific discovery, underscoring Millar’s commitment to advancing medicine through pressure sensor technology.

Tim Daugherty, President and CEO of Millar, said the acquisition of Sentron is a strategic business move and a leap forward for the company toward future innovation. He highlighted that Sentron’s technology and manufacturing capabilities complement Millar’s own strengths, enabling Millar to offer sensing solutions more comprehensively to customers around the world. This collaboration is expected to enable Millar to redefine the landscape of the MEMS pressure sensor industry, driving industry advancements and improving global healthcare outcomes.

T8111C

As part of the acquisition, Millar will expand its global presence, enhance product distribution capabilities, and become a one-stop supplier for sensor development, from original chips to fully commercialized sensor medical devices. The combination, which also includes sensor development and manufacturing facilities, will significantly expand Millar’s range of capabilities, enabling it to offer a broader range of sensing solutions, including pH and conductivity sensors. This not only enriches Millar’s product portfolio, it will also position it as a leader in integrated sensor solutions to power the future of medical technology.

Wellinq CEO Sander Hartman expressed enthusiasm for the acquisition, calling it a landmark step for Sentron. He highlighted Millar’s reputation for excellence and commitment to medical research, arguing that the combination of the two companies will pave the way for groundbreaking advances in medical sensor technology. He also looks forward to the opportunity this partnership will provide for Wellinq and Millar to work together to create an even greater positive impact on patient outcomes.

Overall, Millar’s acquisition of Sentron is not only a pivotal moment in the development of both companies, but also a major boost to further innovation in MEMS and sensor technology in healthcare. This will provide more advanced tools for medical research, which is expected to drive more innovation and improve the effectiveness of medical technology in the future.